Design of phase-I trials of immunopotentiators for cancer therapy: levamisole and Corynebacterium parvum.
D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D011425:Propionibacterium acnes / Q000276:immunology*; D012107:Research Design
D007978:Levamisole